As shown in Figure 2, serum ANGPTL4 concentrations were 11.2 ± 5.4, 11.7 ± 16.7, 23.8 ± 11.9, 29.6 ± 26.9, 10.9 ± 5.8, 14.3 ± 14.5, 20.4 ± 7.9, 25.0 ± 10.9 ng/mL in subjects with NGT, IFG, IGT, NDD, NGT + hepatic steatosis, IFG + hepatic steatosis, IGT + hepatic steatosis, NDD + hepatic steatosis, respectively. This evidence concerns the gene ANGPTL4 and fatty liver disease.